A health economic model to estimate the costs and benefits of an mRNA vs DNA high-risk HPV assay in a hypothetical HPV primary screening algorithm in Ontario, Canada.

Weston, Georgie; Dombrowski, Caroline; Steben, Marc; Popadiuk, Catherine; Bentley, James; Adams, Elisabeth J

Weston, Georgie; Dombrowski, Caroline; Steben, Marc; Popadiuk, Catherine; Bentley, James; Adams, Elisabeth J.

Afiliação

Weston G; Aquarius Population Health, Unit 29 Tileyard Studios, London N7 9AH, UK.
Dombrowski C; Aquarius Population Health, Unit 29 Tileyard Studios, London N7 9AH, UK.
Steben M; School of Public Health, Université de Montréal, Montréal, QC H3N 1X9, Canada.
Popadiuk C; Faculty of Medicine, Memorial University, 300 Prince Philip Drive, St. John's, NL A1B 3V6, Canada.
Bentley J; Nova Scotia Health Authority, Room 5006, Dickson Building, QEII Health Sciences Centre, 5820, University Avenue, Halifax, NS B3H 2Y9, Canada.
Adams EJ; Aquarius Population Health, Unit 29 Tileyard Studios, London N7 9AH, UK.

Prev Med Rep ; 23: 101448, 2021 Sep.

Article em En | MEDLINE | ID: mdl-34381664

Palavras-chave

Cancer screening; Economic model; HPV infection

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Etiology_studies / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Prev Med Rep Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google